Advocacy Wealth Management Services, LLC Bristol Myers Squibb CO Transaction History

Advocacy Wealth Management Services, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 04, 2022	SELL	$61.48 - $73.72 $18,382 - $22,042	-299 Closed	0 $0
Q3 2021 Oct 05, 2021	SELL	$59.17 - $69.31 $53,253 - $62,379	-900 Reduced 75.06%	299 $18,000
Q2 2021 Jul 02, 2021	BUY	$61.91 - $67.42 $55,719 - $60,678	900 Added 301.0%	1,199 $80,000
Q1 2021 Apr 05, 2021	BUY	$59.34 - $66.74 $5,874 - $6,607	99 Added 49.5%	299 $19,000
Q3 2020 Oct 02, 2020	BUY	$57.43 - $63.64 $11,486 - $12,728	200 New	200 $12,000
Q1 2018 Apr 12, 2018	SELL	$59.92 - $68.98 $17,976 - $20,694	-300 Closed	0 $0
Q4 2017 Jan 12, 2018	SELL	$59.94 - $65.35 $17,982 - $19,605	-300 Reduced 50.0%	300 $18,000
Q3 2017 Oct 13, 2017	BUY	$55.23 - $63.74 $33,138 - $38,244	600	600 $38,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Advocacy Wealth Management Services, LLC, based on Form 13F filings with the SEC.

Stay updated on Advocacy Wealth Management Services, LLC with notifications on news.